Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Cash flows from operating activities    
Net income (loss) $ 172 $ (349)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:    
Depreciation and amortization expense 70 24
Share-based compensation expense 24 16
Non-cash interest expense 20 17
Amortization of debt issuance costs, deferred commitment fees, premium and discount 17 13
Loss on early extinguishment of debt 42 1
Total losses on derivatives, net 44 182
Net cash used for settlement of derivative instruments (29) (9)
Impairment expense 0 10
Other 0 1
Changes in operating assets and liabilities:    
Accounts and other receivables (6) 1
Inventory 54 (2)
Accounts payable and accrued liabilities (76) (28)
Deferred revenue (11) (1)
Other, net (12) (7)
Net cash provided by (used in) operating activities 309 (131)
Cash flows from investing activities    
Property, plant and equipment, net (1,319) (1,150)
Other 29 (18)
Net cash used in investing activities (1,290) (1,168)
Cash flows from financing activities    
Proceeds from issuances of debt 2,862 1,908
Repayments of debt (703) (415)
Debt issuance and deferred financing costs (43) (49)
Distributions and dividends to non-controlling interest (20) (20)
Payments related to tax withholdings for share-based compensation (1) (1)
Net cash provided by financing activities 2,095 1,423
Net increase in cash, cash equivalents and restricted cash 1,114 124
Cash, cash equivalents and restricted cash—beginning of period 1,827 1,736
Cash, cash equivalents and restricted cash—end of period 2,941 1,860
Balances per Consolidated Balance Sheets:    
Cash and cash equivalents 923 1,095
Restricted cash 1,000 733
Non-current restricted cash 1,018 32
Total cash, cash equivalents and restricted cash $ 2,941 $ 1,860